Crystallography provides the key building block in such studies (Gomes et al. 2018), as also shown by TrkA (tropomyosin receptor kinase A, a nerve growth factor receptor) and broadly in activating mutations in tyrosine kinase domains in cancer (Artim et al. 2012). This evidence concerns the gene NTRK1 and cancer.